Would you proceed with anti-CD20 treatment in an MS patient who is VZV IgG negative in spite of vaccination in the last year?

There is no clear data on management. In my experience, if a patient has been vaccinated in the recent past, then I will proceed with anti-CD20 therapy. However, if vaccination was in the remote past, I have asked patients to repeat vaccination before initiating therapy.